首页|First Affiliated Hospital of Yangtze University Reports Findings in Gliomas (Non invasive prediction of CCL2 expression level in highgrade glioma patients)
First Affiliated Hospital of Yangtze University Reports Findings in Gliomas (Non invasive prediction of CCL2 expression level in highgrade glioma patients)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Oncology - Gliomas is the subject of a report. According to newsreporting out of Jingzhou, People’s R epublic of China, by NewsRx editors, research stated, “Gliomasare recognized as the most frequent type of malignancies in the central nervous system, and effic aciousprognostic indicators are essential to treat patients with gliomas and im prove their clinical outcomes. Thechemokine (C-C motif) ligand 2 (CCL2) is a pr omising predictor for glioma malignancy and progression.”Financial support for this research came from Natural Science Foundation of Zhej iang Province.
JingzhouPeople’s Republic of ChinaAsiaBiological FactorsCC ChemokinesChemokine CCL2Chemotactic FactorsCyto kinesGliomasHealth and MedicineInflammation MediatorsIntercellular Signa ling Peptides and ProteinsMonocyte Chemoattractant ProteinsOncology
NETL
NSTL
